
CAS 931399-19-8
:Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
GSK360A
CAS:Controlled Product<p>Applications GSK360A orally active HIF-PHD inhibitor. GSK360A exerts systemic and local effects by stabilizing HIF-1α signaling and improves long-term ventricular function, remodeling, and vascularity in a model of established ventricular dysfunction. These findings suggest that GSK360A may be suitable for the treatment of post-MI remodeling and heart failure.<br>References Bao, W.-K. et al.: J. Cardio. Pharmacol., 56, 147 (2010);<br></p>Formula:C17H17FN2O5Color and Shape:NeatMolecular weight:348.33GSK 360A
CAS:<p>Inhibitor of prolyl 4-hydroxylase PHD</p>Formula:C17H17FN2O5Purity:Min. 95%Color and Shape:PowderMolecular weight:348.33 g/molGSK360A
CAS:GSK360A is a novel prolyl hydroxylase (PHD) domain-containing enzyme inhibitor.Formula:C17H17FN2O5Purity:98%Color and Shape:SolidMolecular weight:348.33


